MiR-203 has been characterized to act as a tumor suppressor microRNA in laryngeal carcinoma by targeting survivin [58] and in lung cancer by targeting v-src avian sarcoma viral oncogene (SRC) and protein kinase C alpha (PKCα/PRKCA) [57,59]. This evidence concerns the gene BIRC5 and laryngeal carcinoma.